These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33155912)

  • 1. Potential Role of miRNA in Metastatic Cascade of Triple-Negative Breast Cancer.
    Balkrishna A; Mittal R; Arya V
    Curr Cancer Drug Targets; 2021; 21(2):153-162. PubMed ID: 33155912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling Role of MicroRNAs as Treatment Strategy and Prognostic Markers in Triple Negative Breast Cancer.
    Balkrishna A; Mittal R; Arya V
    Curr Pharm Biotechnol; 2020; 21(15):1569-1575. PubMed ID: 32593278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance and Applications in Human Triple-Negative Breast Cancer.
    Ding L; Gu H; Xiong X; Ao H; Cao J; Lin W; Yu M; Lin J; Cui Q
    Cells; 2019 Nov; 8(12):. PubMed ID: 31766744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.
    Xu X; Zhang Y; Jasper J; Lykken E; Alexander PB; Markowitz GJ; McDonnell DP; Li QJ; Wang XF
    Oncotarget; 2016 Apr; 7(15):20381-94. PubMed ID: 26967387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Suppressive Role of MicroRNAs in Triple Negative Breast Cancer.
    Balkrishna A; Mittal R; Arya V
    Curr Pharm Des; 2023; 29(42):3357-3367. PubMed ID: 38037837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNAs Predict the Prognosis of Patients with Triple Negative Breast Cancer: A Meta-Analysis.
    Liu Y; Zhang Y; Li Q; Li J; Ma X; Xing J; Rong S; Wu Z; Tian Y; Li J; Jia L
    PLoS One; 2017; 12(1):e0170088. PubMed ID: 28085956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
    Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
    Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
    Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
    Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease.
    Qattan A
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling Role of MicroRNAs in Metastasizing Triple Negative Breast Cancer: From Therapeutics to Delivery.
    Balkrishna A; Mittal R; Arya V
    Curr Drug Targets; 2023; 24(6):509-520. PubMed ID: 36892021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling Novel Therapeutic Drug Targets and Prognostic Markers of Triple Negative Breast Cancer.
    Balkrishna A; Mittal R; Arya V
    Curr Cancer Drug Targets; 2021; 21(11):907-918. PubMed ID: 34503412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the Novel Tumor Suppressor Role of FOCAD/miR-491-5p to Inhibit Cancer Stemness, Drug Resistance and Metastasis via Regulating RABIF/MMP Signaling in Triple Negative Breast Cancer.
    Huang WC; Chi HC; Tung SL; Chen PM; Shih YC; Huang YC; Chu PY
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-1976 knockdown promotes epithelial-mesenchymal transition and cancer stem cell properties inducing triple-negative breast cancer metastasis.
    Wang J; Li M; Han X; Wang H; Wang X; Ma G; Xia T; Wang S
    Cell Death Dis; 2020 Jul; 11(7):500. PubMed ID: 32620748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel genes associated with lymph node metastasis in triple negative breast cancer.
    Mathe A; Wong-Brown M; Morten B; Forbes JF; Braye SG; Avery-Kiejda KA; Scott RJ
    Sci Rep; 2015 Nov; 5():15832. PubMed ID: 26537449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator.
    Chen H; Li Z; Zhang L; Zhang L; Zhang Y; Wang Y; Xu M; Zhong Q
    Ann Clin Lab Sci; 2020 Jul; 50(4):519-527. PubMed ID: 32826250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple negative breast cancer in the era of miRNA.
    Sabit H; Cevik E; Tombuloglu H; Abdel-Ghany S; Tombuloglu G; Esteller M
    Crit Rev Oncol Hematol; 2021 Jan; 157():103196. PubMed ID: 33307198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.
    Wu J; Li WZ; Huang ML; Wei HL; Wang T; Fan J; Li NL; Ling R
    Biochem Biophys Res Commun; 2017 Jan; 483(1):10-16. PubMed ID: 28069384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.
    Wang PS; Chou CH; Lin CH; Yao YC; Cheng HC; Li HY; Chuang YC; Yang CN; Ger LP; Chen YC; Lin FC; Shen TL; Hsiao M; Lu PJ
    Oncogene; 2018 Aug; 37(34):4662-4678. PubMed ID: 29755127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.